SERINC2
Basic information
Region (hg38): 1:31409565-31434680
Previous symbols: [ "TDE2L" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SERINC2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 45 | 50 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 45 | 5 | 3 |
Variants in SERINC2
This is a list of pathogenic ClinVar variants found in the SERINC2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-31423768-C-T | EBV-positive nodal T- and NK-cell lymphoma | Likely benign (-) | ||
1-31423834-G-A | not specified | Uncertain significance (Feb 10, 2023) | ||
1-31424687-C-T | not specified | Uncertain significance (Oct 12, 2021) | ||
1-31424690-G-C | not specified | Uncertain significance (Dec 14, 2021) | ||
1-31424705-G-A | not specified | Uncertain significance (May 15, 2023) | ||
1-31424709-C-T | Benign (Jul 06, 2018) | |||
1-31424722-G-A | not specified | Likely benign (Aug 15, 2023) | ||
1-31424740-G-A | Benign (Dec 31, 2019) | |||
1-31424762-A-G | not specified | Uncertain significance (Apr 08, 2022) | ||
1-31424765-G-A | not specified | Uncertain significance (Jan 29, 2024) | ||
1-31424776-C-T | not specified | Uncertain significance (Oct 16, 2023) | ||
1-31424777-G-A | not specified | Uncertain significance (Dec 20, 2023) | ||
1-31424807-T-C | not specified | Uncertain significance (Feb 10, 2022) | ||
1-31424825-T-C | not specified | Uncertain significance (Jun 10, 2021) | ||
1-31424828-T-A | not specified | Uncertain significance (Jun 10, 2021) | ||
1-31424830-T-A | not specified | Uncertain significance (Jun 10, 2021) | ||
1-31424833-G-A | not specified | Uncertain significance (Jun 10, 2021) | ||
1-31424845-C-G | Likely benign (Nov 01, 2022) | |||
1-31424845-C-T | Likely benign (Jul 01, 2022) | |||
1-31424854-C-T | not specified | Uncertain significance (Jun 05, 2023) | ||
1-31424863-A-T | not specified | Uncertain significance (Jun 13, 2022) | ||
1-31425370-G-A | not specified | Uncertain significance (Oct 04, 2022) | ||
1-31425374-G-A | not specified | Uncertain significance (Jan 31, 2024) | ||
1-31425394-G-A | not specified | Uncertain significance (Aug 04, 2023) | ||
1-31425850-C-T | not specified | Uncertain significance (Mar 04, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SERINC2 | protein_coding | protein_coding | ENST00000373710 | 11 | 25114 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.92e-13 | 0.0886 | 125511 | 0 | 237 | 125748 | 0.000943 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.262 | 315 | 302 | 1.04 | 0.0000196 | 3024 |
Missense in Polyphen | 156 | 139.74 | 1.1164 | 1435 | ||
Synonymous | -0.688 | 142 | 132 | 1.08 | 0.00000951 | 918 |
Loss of Function | 0.610 | 21 | 24.2 | 0.866 | 0.00000104 | 256 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0120 | 0.0120 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000383 | 0.000381 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000169 | 0.000167 |
Middle Eastern | 0.000383 | 0.000381 |
South Asian | 0.000196 | 0.000196 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Pathway
- Metabolism of amino acids and derivatives;Metabolism;Amino acid synthesis and interconversion (transamination);Serine biosynthesis
(Consensus)
Intolerance Scores
- loftool
- 0.732
- rvis_EVS
- 0.18
- rvis_percentile_EVS
- 66.17
Haploinsufficiency Scores
- pHI
- 0.140
- hipred
- N
- hipred_score
- 0.289
- ghis
- 0.437
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.305
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Serinc2
- Phenotype
Gene ontology
- Biological process
- phosphatidylserine metabolic process;sphingolipid metabolic process;positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity;positive regulation of serine C-palmitoyltransferase activity
- Cellular component
- integral component of membrane;extracellular exosome
- Molecular function